| Bioactivity | KM-001 is a potent and selective TRPV3 antagonist. KM-001 reduces Ca2+ flux in keratinocytes and decreases cell proliferation accompanied by normalization of keratinocyte differentiation markers[1]. |
| Name | KM-001 |
| CAS | 2682864-35-1 |
| Formula | C26H25FN2O2 |
| Molar Mass | 416.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kamari Pharma Ltd, et al. Study Designed to Evaluate the Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases. |